Hydroxychloroquine Inhibits Cardiac Conduction in Aged Patients with Nonmalaria Diseases

Background: The COVID-19 pandemic has brought increased focus on hydroxychloroquine (HCQ), as doctors, the medical community, and policymakers around the world attempt to understand how the risks of HCQ weigh against unknown benefits. We aim to evaluate the effects of HCQ on cardiac conduction, thus...

Full description

Bibliographic Details
Main Authors: Yanting Yu, Jianteng Xu, Anni Xie, Sijia Liu, Xiaojian Wang, Runzhang Zhu, Xiaoyan Wang
Format: Article
Language:English
Published: Karger Publishers 2021-04-01
Series:Kidney Diseases
Subjects:
Online Access:https://www.karger.com/Article/FullText/515278

Similar Items